Financhill
Back

Cerevel Therapeutics Holdings Stock Predictions

S&P Global: Private Equity Invests $36 Billion Into What?

Read More
Buy
57

CERE
Cerevel Therapeutics Holdings

Last Price:
42.38
Seasonality Move:
-0.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Billionaire Investors Join Forces to Fund Next Generation

Learn More

Cerevel Therapeutics Holdings Stock Forecast

  • Over the next 52 weeks, Cerevel Therapeutics Holdings has on average historically risen by 47.9% based on the past 3 years of stock performance.
  • Cerevel Therapeutics Holdings has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Cerevel Therapeutics Holdings Stock Undervalued?
    The current Cerevel Therapeutics Holdings [CERE] share price is $42.34. The Score for CERE is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • CERE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Cerevel Therapeutics Holdings Stock Go Up Next Year?

  • Over the next 52 weeks, Cerevel Therapeutics Holdings has on average historically risen by 47.9% based on the past 3 years of stock performance.

Cerevel Therapeutics Holdings Stock Rating

Buy
57
Cerevel Therapeutics Holdings (CERE) is a Buy

Is Cerevel Therapeutics Holdings overpriced?

  • Cerevel Therapeutics Holdings has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Cerevel Therapeutics Holdings Stock Price History

Is CERE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CERE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
cerevel.com

52-Week Data

52-Week High:
43.59
52-Week Low:
19.59

Prediction Charts

Market Cap:
7.69B
Price in USD:
42.34
Volume:
695.41K
Beta:
1.50

Technical Analysis

SMA50:
41.92
SMA100:
38.12
SMA200:
31.86
52-Wk Change:
79.79%

Stock Predictions

  • Is Cerevel Therapeutics Holdings stock public?
    Yes, Cerevel Therapeutics Holdings is a publicly traded company.
  • What is the Cerevel Therapeutics Holdings stock quote today?
    The Cerevel Therapeutics Holdings stock price is 42.34 USD today.
  • How to buy Cerevel Therapeutics Holdings stock online?
    You can buy Cerevel Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-8 41.37 41.25 41.50 41.10
Mar-11 41.21 41.46 41.49 41.15
Mar-12 41.33 41.88 42.05 41.33
Mar-13 41.96 42.21 42.29 41.88
Mar-14 42.31 42.27 42.41 42.21
Mar-15 42.20 42.33 42.42 42.17
Mar-18 42.37 42.58 42.80 42.35
Mar-19 42.59 42.32 42.70 42.27
Mar-20 42.30 42.31 42.49 42.24
Mar-21 42.40 42.26 42.48 42.21
Mar-22 42.30 42.19 42.39 42.10
Mar-25 42.20 42.40 42.45 42.20
Mar-26 42.48 42.38 42.60 42.24
Mar-27 42.36 42.34 42.52 42.18

Cerevel Therapeutics Holdings Earnings

Cerevel Therapeutics Holdings Earnings Report: Per Share Cerevel Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cerevel Therapeutics Holdings Forecast Revenue Growth

Cerevel Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Cerevel Therapeutics Holdings and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.32 per share.

* Cerevel Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.